Grantham, Mayo, Van Otterloo & Co (GMO)’s Avient AVNT Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNT
MB
CCM
Grantham, Mayo, Van Otterloo & Co (GMO)'s AVNT Position: Q3 2022 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Avient (AVNT) in Q3 2022, closing a stake of 40,258 shares — an estimated $1.61M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AVNT in Q3 2018 and held it in 16 quarters. The position peaked at $12.4M in Q2 2020. 280 funds tracked by Wall St. Rank hold AVNT as of Q3 2022.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Avient position as of Q3 2022 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 40,258 Avient shares in Q3 2022, an estimated $1.61M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Avient in Q3 2018 and held it in 16 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Avient position peaked at $12.4M in Q2 2020.
- 280 funds tracked by Wall St. Rank held Avient as of Q3 2022.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.